FR2004000A1 - - Google Patents

Info

Publication number
FR2004000A1
FR2004000A1 FR6907281A FR6907281A FR2004000A1 FR 2004000 A1 FR2004000 A1 FR 2004000A1 FR 6907281 A FR6907281 A FR 6907281A FR 6907281 A FR6907281 A FR 6907281A FR 2004000 A1 FR2004000 A1 FR 2004000A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR6907281A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Laboratories Ltd
Original Assignee
Glaxo Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Laboratories Ltd filed Critical Glaxo Laboratories Ltd
Publication of FR2004000A1 publication Critical patent/FR2004000A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR6907281A 1968-03-15 1969-03-14 Withdrawn FR2004000A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1273268A GB1268773A (en) 1968-03-15 1968-03-15 NOVEL alpha-CARBOLINE DERIVATIVES, THE PREPARATION THEREOF AND COMPOSITIONS CONTAINING THE SAME

Publications (1)

Publication Number Publication Date
FR2004000A1 true FR2004000A1 (fr) 1969-11-14

Family

ID=10010080

Family Applications (1)

Application Number Title Priority Date Filing Date
FR6907281A Withdrawn FR2004000A1 (fr) 1968-03-15 1969-03-14

Country Status (9)

Country Link
AT (2) AT305277B (fr)
BE (1) BE729854A (fr)
CH (1) CH529155A (fr)
DE (1) DE1913124A1 (fr)
FR (1) FR2004000A1 (fr)
GB (1) GB1268773A (fr)
IE (1) IE32706B1 (fr)
NL (1) NL6903974A (fr)
SE (1) SE370399B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4952584A (en) * 1986-01-11 1990-08-28 Beecham Group P.L.C. 9H-pyrido[2,B-8]indole-3-carboxylic acid ester compounds having useful pharmaceutical activity
GB8600651D0 (en) * 1986-01-11 1986-02-19 Beecham Group Plc Compounds
US6147085A (en) * 1999-04-01 2000-11-14 Neurogen Corporation Aminoalkyl substituted 9H-pyridino[2,3-b] indole and 9H-pyrimidino[4,5-b] indole derivatives
US8119655B2 (en) 2005-10-07 2012-02-21 Takeda Pharmaceutical Company Limited Kinase inhibitors
US20100120717A1 (en) 2006-10-09 2010-05-13 Brown Jason W Kinase inhibitors
EP2161271A1 (fr) * 2008-09-08 2010-03-10 Università Degli Studi Di Milano - Bicocca Inhibiteurs d'alpha-carboline de NMP-ALK, RET, et Bcr-Abl
CA2960101C (fr) 2014-09-05 2024-05-21 Allosteros Therapeutics, Inc. Derive de carboline substituee et compositions connexes utiles comme inhibiteurs de camkii

Also Published As

Publication number Publication date
IE32706B1 (en) 1973-10-31
SE370399B (fr) 1974-10-14
GB1268773A (en) 1972-03-29
IE32706L (en) 1969-09-15
BE729854A (fr) 1969-09-15
NL6903974A (fr) 1969-09-17
CH529155A (de) 1972-10-15
DE1913124A1 (de) 1969-10-02
AT306713B (de) 1973-04-25
AT305277B (de) 1973-02-26

Similar Documents

Publication Publication Date Title
AU1946070A (fr)
AU5506869A (fr)
AU2374870A (fr)
AU5184069A (fr)
AU6168869A (fr)
FR2004000A1 (fr)
AU6171569A (fr)
AU416157B2 (fr)
AU2581067A (fr)
AU4811568A (fr)
AU3224368A (fr)
AU2580267A (fr)
AR203075Q (fr)
AU3789668A (fr)
BE709435A (fr)
BE709138A (fr)
BE723586A (fr)
BE713863A (fr)
BE709496A (fr)
BE709484A (fr)
BE709479A (fr)
BE709446A (fr)
BE723740A (fr)
BE708951A (fr)
BE724027A (fr)

Legal Events

Date Code Title Description
ST Notification of lapse